Anzeige
Mehr »
Login
Samstag, 02.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
Technischer Ausbruch: Diese Kupferaktie ist in den letzten 52 Wochen um 300 % gestiegen! Der Durchbruch läuft!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
633 Leser
Artikel bewerten:
(2)

TraceSafe Inc.: TraceSafe Secures New Order in Hong Kong for Quarantine Management Wristbands

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

TraceSafe awarded order for 120,000 e-wristbands from Hong Kong government

TORTOLA, BRITISH VIRGIN ISLANDS / ACCESSWIRE / September 10, 2020 / TraceSafe Inc. ("Tracesafe") (CSE:TSF) a global leader in wearable safety tech including contact tracing and self-quarantine management, is pleased to announce continued purchases through a successful bid towards a competitive open tender issued by the Hong Kong Government. The Office of the Government Chief Information Officer (OGCIO) confirmed the award of 120,000 TraceSafe e-wristbands to be used in Hong Kong's Home Quarantine Support System.

TraceSafe's disposable wristbands have been utilized in Hong Kong since the end of March this year to assist the OGCIO in managing and enforcing its quarantine program for foreign visitors and returning citizens. TraceSafe first provided the government of Hong Kong with disposable monitoring wristbands, which were provided by healthcare providers and authorities at airports. The wristbands connect with software that allow the Hong Kong government to enforce quarantine amongst travelers and those who tested positive for COVID-19. These and other measures have been used by the Hong Kong government to fight and control the spread of the virus within its borders.

Executive Quote

"We are pleased with the ongoing deployment of TraceSafe's wristband technology in Hong Kong and our most recent contract is a testament to the utility of the TraceSafe technology. We are very excited to continue working with Hong Kong authorities to help prevent the spread of COVID-19," said Dennis Kwan, CEO of TraceSafe Technologies Inc. "TraceSafe is a significant tool to help not only manage quarantine, but to provide a safer environment through real-time contact tracing in work spaces. We are pleased that TraceSafe is an optimum solution for the Hong Kong OGCIO."

About TraceSafe

TraceSafe is a full suite of real-time location management services and contact tracing solutions enabled through advanced low power bluetooth beacons and enterprise cloud management. TraceSafe's leading cloud management solution ensures both user privacy and comprehensive administrative control. TraceSafe's patented contact tracing bracelet has already been deployed in mission critical quarantine applications around the world in partnership with leading governments. In addition to their government work, TraceSafe is developing leading edge solutions for Enterprise, Healthcare, Education Government and large-scale venue management.

For further information, please contact:

Wayne Lloyd, CEO
+1 604 629-9975
wayne@tracesafe.io

Alan Tam, CFO
+1 604 377-7575
alantamca@gmail.com

John Costigan
+1 604 620-8589
jcostigan@ecmbcapital.com

The Canadian Securities Exchange has in no way approved or disapproved the contents of this news release.

Statements in this news release may contain forward-looking statements that are based on TraceSafe's expectations, estimates and projections regarding its business and the economic environment in which it operates, including with respect to expectations regarding the TraceSafe assets and their application, future business plans and relationships, future developments in respect of COVID-19 and solutions adopted in response to the virus, and the deployment and acceptance of the TraceSafe technology. Although TraceSafe believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict, including the suitability of our products to help businesses and governments reopen, competition, the spread or containment of COVID-19 and government responses thereto and general economic and market conditions. Therefore, outcomes and results may differ materially from those expressed in these forward-looking statements and readers should not place undue reliance on such statements. These forward-looking statements speak only as of the date on which they are made, and TraceSafe undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances unless otherwise required to do so by law.

SOURCE: TraceSafe Inc.



View source version on accesswire.com:
https://www.accesswire.com/605533/TraceSafe-Secures-New-Order-in-Hong-Kong-for-Quarantine-Management-Wristbands

© 2020 ACCESSWIRE
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.